Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$225.07 - $246.17 $450 - $492
2 New
2 $0
Q4 2023

Feb 13, 2024

BUY
$232.24 - $267.23 $232 - $267
1 New
1 $0
Q2 2023

Aug 14, 2023

SELL
$238.39 - $265.32 $44,340 - $49,349
-186 Reduced 33.45%
370 $98,000
Q1 2023

May 12, 2023

BUY
$229.71 - $259.35 $61,332 - $69,246
267 Added 92.39%
556 $138,000
Q4 2022

Feb 13, 2023

BUY
$218.29 - $256.91 $62,867 - $73,990
288 Added 28800.0%
289 $73,000
Q3 2022

Nov 02, 2022

SELL
$51.03 - $264.23 $30,311 - $156,952
-594 Reduced 99.83%
1 $0
Q2 2022

Aug 02, 2022

BUY
$234.74 - $275.42 $112,205 - $131,650
478 Added 408.55%
595 $147,000
Q1 2022

May 11, 2022

BUY
$243.64 - $270.48 $28,505 - $31,646
117 New
117 $31,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Clear Street Markets LLC Portfolio

Follow Clear Street Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Street Markets LLC with notifications on news.